Phase I/II study testing the combination of AGuIX nanoparticles with radiochemotherapy and concomitant temozolomide in patients with newly diagnosed glioblastoma (NANO-GBM trial protocol)

被引：0
|
作者：
Emilie Thivat
Mélanie Casile
Juliette Moreau
Ioana Molnar
Sandrine Dufort
Khalide Seddik
Géraldine Le Duc
Olivier De Beaumont
Markus Loeffler
Xavier Durando
Julian Biau
机构：
[1] Centre Jean Perrin,Department of Clinical Research, Délégation Recherche Clinique Et Innovation
[2] INSERM U1240 IMoST,Department of Radiation Oncology
[3] Université Clermont Auvergne,Oncology Department
[4] UMR 501,undefined
[5] Centre d’Investigation Clinique,undefined
[6] Centre Jean Perrin,undefined
[7] NH TherAguix SA,undefined
[8] Centre Jean Perrin,undefined
来源：
BMC Cancer | / 23卷
关键词：
Glioblastoma; Nanoparticles; AGuIX; Nanomedicine; Radiotherapy; Radiosensitization;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Phase I/II study testing the combination of AGuIX nanoparticles with radiochemotherapy and concomitant temozolomide in patients with newly diagnosed glioblastoma (NANO-GBM trial protocol)
    Thivat, Emilie
    Casile, Melanie
    Moreau, Juliette
    Molnar, Ioana
    Dufort, Sandrine
    Seddik, Khalide
    Le Duc, Geraldine
    De Beaumont, Olivier
    Loeffler, Markus
    Durando, Xavier
    Biau, Julian
    BMC CANCER, 2023, 23 (01)
  • [2] NANO-GBM trial of AGuIX nanoparticles with radiotherapy and temozolomide in the treatment of newly diagnosed Glioblastoma: Phase 1b outcomes and MRI-based biodistribution
    Biau, J.
    Durando, X.
    Boux, F.
    Molnar, I.
    Moreau, J.
    Leyrat, B.
    Guillemin, F.
    Lavielle, A.
    Cremillieux, Y.
    Seddik, K.
    Dufort, S.
    De Beaumont, O.
    Thivat, E.
    Le Duc, G.
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2024, 48
  • [3] A PHASE I TRIAL OF AFATINIB AND RADIOTHERAPY (RT) WITH OR WITHOUT TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Saran, Frank
    James, Allan
    McBain, Catherine
    Jefferies, Sarah
    Harris, Fiona
    Cseh, Agnieszka
    Pemberton, Karine
    Schaible, Jennifer
    Bender, Shaun
    Brada, Michael
    NEURO-ONCOLOGY, 2018, 20 : 20 - 20
  • [4] PHASE I/II STUDY TO EVALUATE THE SAFETY AND CLINICAL EFFICACY OF ATEZOLIZUMAB (ATEZO) IN COMBINATION WITH TEMOZOLOMIDE (TMZ) AND RADIATION IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Weathers, Shiao-Pei
    Kamiya-Matsuoka, Carlos
    Harrison, Rebecca
    Liu, Diane
    Sanqui, Edmund
    Dervin, Shannon
    Yun, Cindy
    Loghin, Monica
    Penas-Prado, Marta
    Majd, Nazanin
    Yung, W. K. Alfred
    O'Brien, Barbara
    de Groot, John
    NEURO-ONCOLOGY, 2020, 22 : 35 - 35
  • [5] Phase I, open-label, multicentre study of buparlisib in combination with temozolomide or with concomitant radiation therapy and temozolomide in patients with newly diagnosed glioblastoma
    Wen, Patrick Yung
    Rodon, Jordi A.
    Mason, Warren
    Beck, Joseph T.
    DeGroot, John
    Donnet, Valerie
    Mills, David
    El-Hashimy, Mona
    Rosenthal, Mark
    ESMO OPEN, 2020, 5 (04)
  • [6] Phase I/II study of pazopanib and temozolomide in patients with newly diagnosed and resected glioblastoma: Pazoglio trial.
    Saada-Bouzid, Esma
    Frenel, Jean-Sebastien
    Augereau, Paule
    Bourg, Veronique
    Gal, Jocelyn
    Jacquinot, Rique
    Gourmelon, Carole
    Chateau, Yann
    Barriere, Jerome
    Bondiau, Pierre-Yves
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] Phase II trial of talampanel in conjunction with standard radiation (RT) and temozolomide (TMZ) in patients with newly diagnosed glioblastoma (GBM)
    Grossman, S. A.
    Ye, X.
    Chamberlain, M. C.
    Mikkelsen, T.
    Batchelor, T. T.
    Desideri, S.
    Piantadosi, S.
    Fine, H. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] PHASE I/II TRIAL OF RADIATION THERAPY, TEMOZOLOMIDE AND PEMBROLIZUMAB FOLLOWED BY TEMOZOLOMIDE AND PEMBROLIZUMAB IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Dixit, Karan
    Kumthekar, Priya
    Kruser, Timothy
    Bloch, Orin
    Chandler, James
    Tate, Matthew
    Raizer, Jeffrey
    NEURO-ONCOLOGY, 2016, 18 : 19 - 19
  • [9] Phase I/IIa trial of cilengitide (EMD121974) and temozolomide with concomitant radiotherapy, followed by temozolomide and cilengitide maintenance therapy in patients (pts) with newly diagnosed glioblastoma (GBM)
    Stupp, R.
    Goldbrunner, R.
    Neyns, B.
    Schlegel, U.
    Clement, P.
    Grabenbauer, G. G.
    Hegi, E.
    Nippgen, J.
    Picard, M.
    Weller, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] RADIOCHEMOTHERAPY WITH DAILY CONCOMITANT AND ADJUVANT ONE WEEK ON/ONE WEEK OFF TEMOZOLOMIDE PLUS INDOMETHACIN IN NEWLY DIAGNOSED GLIOBLASTOMA: A PHASE II TRIAL
    Weiler, M.
    Hartmann, C.
    Wiewrodt, D.
    Herrlinger, U.
    Bamberg, M.
    von Deimling, A.
    Weller, M.
    Wick, W.
    NEURO-ONCOLOGY, 2008, 10 (06) : 1074 - 1074
12345